| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |